In this column, Elissa offers wisdom on nutrition, how to support a healthy immune system, and more.
:
They are easy to take, well-studied, and have a solid safety record at doses up to 500 mg per day
Monti-Rocha R, Cramer A, Leite PG, Antunes MM, Pereira RVS, Barroso A, et al
Based on evidence from completed cardiovascular and kidney outcome trials, organizations like the American Diabetes Association (ADA), the American Association of Clinical Endocrinologists (AACE)/American College of Endocrinology (ACE), the American College of Cardiology (ACC), and Kidney Disease: Improving Global Outcomes (KDIGO) note the glycemic, weight, and organ protective benefits of GLP-1 RAs
The Noom Engagement Report: New Data Shows that the GLP-1 Patients Who Use Noom the Most Also Lose the Most Weight and Stay On Medication Program Longest